Article Text

PDF
Review
Endoscopic submucosal dissection and its potential role in the management of early colorectal neoplasia in UK
  1. Christopher Hayward1,
  2. Toshio Uraoka2,
  3. Naohisa Yahagi2
  1. 1Department of Gastroenterology, Derriford Hospital, Plymouth, Devon, UK
  2. 2Division of Research & Development for Minimally Invasive Treatment, Cancer Centre, Keio University School of Medicine, Tokyo, Japan
  1. Correspondence to Dr Christopher Hayward, Consultant Gastroenterologist, Department of Gastroenterology, Derriford Hospital, Derriford Lane, Plymouth, Devon PL6 8DH, UK; chrishayward{at}nhs.net

Abstract

In Europe, colorectal cancer is the most common newly diagnosed cancer and the second most common cause of cancer deaths, accounting for approximately 436 000 incident cases and 212 000 deaths in 2008. National screening programmes will increase the number of early (pT1) cancers detected. pT1 cancers are those showing invasion through the muscularis mucosae into the submucosa but not into the muscularis propria. Microstaging of pT1 cancer is crucial in predicting those cases less likely to cause nodal disease and that will be cured with endoscopic resection alone. The submucosal extent and other histological features predict the risk of nodal disease, and for this reason, en bloc resection is highly desirable. Endoscopic submucosal dissection enables en bloc resection of mucosal and submucosal disease and could reduce the need for surgery in some cases by definitive initial resection.

  • Colonoscopy
  • Colorectal Cancer
  • Endoscopic Polypectomy

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.